|Bid||0.1718 x 900|
|Ask||0.1729 x 1000|
|Day's Range||0.1650 - 0.2090|
|52 Week Range||0.0200 - 1.6000|
|Beta (5Y Monthly)||1.62|
|PE Ratio (TTM)||N/A|
|Earnings Date||Dec 29, 2021 - Jan 03, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Subscribe to Yahoo Finance Plus to view Fair Value for TLGTLearn more
Gainers LM Funding America, Inc. (NASDAQ: LMFA) rose 39.5% to $4.80 in pre-market trading after declining around 15% on Thursday. The company recently announced it purchased an additional 4,000 S19J Pro Antminer Machines for a price of $25.3 million to further expand the company's mining capabilities. ABVC BioPharma, Inc. (NASDAQ: ABVC) rose 24.4% to $3.06 in pre-market trading after gaining around 5% on Thursday. ABVC BioPharma recently restructured its joint venture with Lucida. Avadel Pharmac
South Jersey specialty generic pharmaceutical firm Teligent Inc. filed for voluntarily bankruptcy protection on Thursday as it pursues the sale of the company or its core assets. Teligent Inc. of Buena in Atlantic County also said it is arranging for $12 million debtor-in-possession financing from its senior secured lenders. The company also announced that CEO Tim Sawyer and Philip Yachmetz, Teligent's chief legal officer and executive vice president, resigned effective Oct. 8.
Teligent, Inc. (Nasdaq: TLGT), a New Jersey-based specialty generic pharmaceutical company ("Teligent" or the "Company"), today announced that the Company has, together with certain of its affiliates, filed for voluntary protection under Chapter 11 of the U.S. Bankruptcy Code in the United States Bankruptcy Court for the District of Delaware to pursue a sale process that is intended to maximize the value of the Company.